Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Gene J. Abel who wrote (563)	12/14/1997 11:49:00 PM
From: Michael Burry	Respond to of 2068

Gene, I am just presenting my analysis. I welcome views that provide substantive positive findings as well. My point in mentioning that the article was pre-announcement is that public knowledge about OXHP's problems are very different now than when that article was written. <<I really wish you could squeeze a little silver lining over the fact that 75% of their business is profitable, they recognize their flaws and their try to fix them.>> There is a lot of silver lining here, which I have pointed out in the past many, many times over (1) their patients chose them the best health plan both in May and September (2) the the company's innovations are its strengths and these innovations are not at all the cause of the problems (as has been mistakenly reported) (3) management is visionary which is more than can be said for most insurance executives (4) they continue to have a geographic franchise which makes the plan attractive as a takeover (something that may be more likely to happen now that the executives are known to be seeking seasoned guidance and now that the financial condition has worsened) etc. Heck, I wrote a whole article that thousands of people saw touting Oxford back when it was at $25. There is room here for balanced and unbalanced analysis. Good Investing, Michael Burry